Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

“…Results demonstrate that TPP derivatives decrease melanoma cell viability and clonogenic survival; and there is a structure-activity relationship between TPP side chain length and decreased viability and clonogenic survival.…”

Raw data used to calculate the statistical significances stated in the result section. by Tom Adriaenssens (397863)

Subjects: “…Cell Biology…”

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…Further, there is a structure-activity relationship between TPP side chain length and metabolic disruption; with inclusion of longer side chains resulting in the greatest decreases in mitochondria membrane potential and DHE oxidation.…”

Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs. by Pingling Kwok (14896191)

Subjects:

TPP decreases melanoma tumor growth rate when administered via hydrogel. by Kyle C. Kloepping (9928265)

Demand-side global autocorrelation analysis. by Shuang Lu (504608)

“…Based on land-use data for Jinan from 2006 to 2018, and using the spatial measurement tool GeoDa, we found that both green and residential space have increased significantly in central Jinan. …”

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Table_1_Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity.docx by Xiufeng Cong (10361204)

“…<p>Various nanocarriers with tumor targeting ability and improved pharmacokinetic property have been extensively utilized to reduce the toxicity of existing clinical chemotherapeutics. Herein, we showed that by encapsulating angiogenesis inhibitor anlotinib into polymeric nanoparticles, we could significantly decrease its in vivo toxicity. …”

Table_2_Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity.docx by Xiufeng Cong (10361204)

“…<p>Various nanocarriers with tumor targeting ability and improved pharmacokinetic property have been extensively utilized to reduce the toxicity of existing clinical chemotherapeutics. Herein, we showed that by encapsulating angiogenesis inhibitor anlotinib into polymeric nanoparticles, we could significantly decrease its in vivo toxicity. …”

Raw data. by Pingling Kwok (14896191)

Subjects:

The diagram shows the mean IC-volume of both sides as a function of age with the degree of hearing loss as defined in the methods from class 1 (normal to moderate in both ears) to... by Pingling Kwok (14896191)

Subjects:

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

Subjects:

The volume of the right (red) and left (blue) IC are shown as a function of age on a logarithmic scale. by Pingling Kwok (14896191)

Subjects:

Fig 1 - by Pingling Kwok (14896191)

Subjects:

The diagram plots the volume of the “normal” IC (opposite to the ear with normal hearing <40dB loss; y-axis) as a function of the volume of the “deprived” IC (opposite to the ear w... by Pingling Kwok (14896191)

Subjects:

Proteins from volcano plot which had notable increases or decreases listed in order of greatest to least significance (adjusted p-values). by Eiman Y. Ibrahim (10731078)

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... by Yuki Oichi (11840776)

“…<p>(A) shows the carotid canal area compared between the affected side and the unaffected side in patients with unilateral moyamoya disease, and the unaffected side is significantly wider than the affected side (p = 0.018). …”

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Contains R code utilized in the analyses. by Arttu Autio-Kimura (20454681)

Subjects: “…Cell Biology…”